{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:54:05Z","timestamp":1789894445660,"version":"4.0.1"},"reference-count":45,"publisher":"The Endocrine Society","issue":"2","funder":[{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00c3-fico y Tecnol\u00c33gico","doi-asserted-by":"publisher","award":["1150437"],"award-info":[{"award-number":["1150437"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00c3-fico y Tecnol\u00c33gico","doi-asserted-by":"publisher","award":["1160695"],"award-info":[{"award-number":["1160695"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00c3-fico y Tecnol\u00c33gico","doi-asserted-by":"publisher","award":["1160836"],"award-info":[{"award-number":["1160836"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00c3-fico y Tecnol\u00c33gico","doi-asserted-by":"publisher","award":["150023"],"award-info":[{"award-number":["150023"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Milenio en Inmunolog\u00c3-a e Inmunoterapia","award":["P09\/16-F"],"award-info":[{"award-number":["P09\/16-F"]}]},{"name":"CETREN-UC"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1210\/jc.2018-01197","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T04:59:44Z","timestamp":1537073984000},"page":"595-603","source":"Crossref","is-referenced-by-count":41,"title":["Clinical, Biochemical, and Genetic Characteristics of \u201cNonclassic\u201d Apparent Mineralocorticoid Excess Syndrome"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-1468","authenticated-orcid":false,"given":"Alejandra","family":"Tapia-Castillo","sequence":"first","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Center for Genetics and Genomics, School of Medicine, Cl\u00ednica Alemana-Universidad del Desarrollo, Lo Barnechea, Chile"},{"name":"Millennium Institute on Immunology and Immunotherapy (IMII), Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Baudrand","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Campino","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute on Immunology and Immunotherapy (IMII), Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel","family":"Allende","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratories, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Valdivia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vecchiola","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute on Immunology and Immunotherapy (IMII), Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F","family":"Lagos","sequence":"additional","affiliation":[{"name":"Millennium Institute on Immunology and Immunotherapy (IMII), Santiago, Chile"},{"name":"Department of Clinical Laboratories, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crist\u00f3bal A","family":"Fuentes","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Solari","sequence":"additional","affiliation":[{"name":"Facultad de Medicina y Ciencia, Universidad San Sebasti\u00e1n, Campus Los Leones, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00ednez-Aguayo","sequence":"additional","affiliation":[{"name":"Endocrinology Pediatrics Division, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Endocrinology Pediatrics Division, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian A","family":"Carvajal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute on Immunology and Immunotherapy (IMII), Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E","family":"Fardella","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute on Immunology and Immunotherapy (IMII), Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"issue":"4812","key":"2019041117530940400_B1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"issue":"12","key":"2019041117530940400_B2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbadis.2009.10.017","article-title":"The role of 11\u03b2-hydroxysteroid dehydrogenase type 2 in human hypertension","volume":"1802","author":"Ferrari","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2019041117530940400_B3","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1210\/jc.2002-021909","article-title":"Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess","volume":"88","author":"Carvajal","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117530940400_B4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jsbmb.2016.03.010","article-title":"Apparent mineralocorticoid excess","volume":"165","author":"Funder","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"2019041117530940400_B5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/jhh.2012.67","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis","volume":"27","author":"Kosicka","year":"2013","journal-title":"J Hum Hypertens"},{"issue":"5","key":"2019041117530940400_B6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041117530940400_B7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.beem.2011.11.006","article-title":"Subclinical primary aldosteronism","volume":"26","author":"Ito","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2019041117530940400_B8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"issue":"9","key":"2019041117530940400_B9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"issue":"8","key":"2019041117530940400_B10","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/ajh\/hpy051","article-title":"Serum cortisol and cortisone as potential biomarkers of partial 11\u03b2-hydroxysteroid dehydrogenase type 2 deficiency","volume":"31","author":"Carvajal","year":"2018","journal-title":"Am J Hypertens"},{"issue":"1","key":"2019041117530940400_B11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004872-200501000-00015","article-title":"Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives","volume":"23","author":"Carvajal","year":"2005","journal-title":"J Hypertens"},{"issue":"8","key":"2019041117530940400_B12","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1093\/ajh\/hpx065","article-title":"Hypertensive patients that respond to aldosterone antagonists may have a nonclassical 11\u03b2-HSD2 deficiency","volume":"30","author":"Tapia-Castillo","year":"2017","journal-title":"Am J Hypertens"},{"issue":"1","key":"2019041117530940400_B13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12020-009-9269-9","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type-2 and type-1 (11\u03b2-HSD2 and 11\u03b2-HSD1) and 5\u03b2-reductase activities in the pathogenia of essential hypertension","volume":"37","author":"Campino","year":"2010","journal-title":"Endocrine"},{"issue":"4","key":"2019041117530940400_B14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ajh\/hps080","article-title":"Age-related changes in 11\u03b2-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects","volume":"26","author":"Campino","year":"2013","journal-title":"Am J Hypertens"},{"issue":"3\u20135","key":"2019041117530940400_B15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jsbmb.2007.03.020","article-title":"Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol","volume":"104","author":"Morris","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2019041117530940400_B16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"2019041117530940400_B17","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APHA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2018;71(19):2275\u20132279]","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2019041117530940400_B18","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"2019041117530940400_B19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","journal-title":"Pediatrics"},{"issue":"24","key":"2019041117530940400_B20","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2169\/internalmedicine.47.1165","article-title":"Spironolactone effective hypertension in the elderly due to 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) impairment: contributory role of determining serum cortisol\/cortisone ratio as a marker of 11beta-HSD2 activity","volume":"47","author":"Inada","year":"2008","journal-title":"Intern Med"},{"issue":"5","key":"2019041117530940400_B21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2011.04308.x","article-title":"Birth weight is inversely associated with blood pressure and serum aldosterone and cortisol levels in children","volume":"76","author":"Martinez-Aguayo","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2019041117530940400_B22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/meta.2001.24213","article-title":"Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone\/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure","volume":"50","author":"Homma","year":"2001","journal-title":"Metabolism"},{"issue":"9","key":"2019041117530940400_B23","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/HJH.0000000000001017","article-title":"Cortisol\/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension","volume":"34","author":"Martinez-Aguayo","year":"2016","journal-title":"J Hypertens"},{"issue":"10","key":"2019041117530940400_B24","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/ajh\/hpw056","article-title":"Usefulness and pitfalls in sodium intake estimation: comparison of dietary assessment and urinary excretion in chilean children and adults","volume":"29","author":"Campino","year":"2016","journal-title":"Am J Hypertens"},{"issue":"19","key":"2019041117530940400_B25","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2019041117530940400_B26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ajh\/hpt277","article-title":"Polymorphisms in the RAC1 gene are associated with hypertension risk factors in a Chilean pediatric population","volume":"27","author":"Tapia-Castillo","year":"2014","journal-title":"Am J Hypertens"},{"issue":"6","key":"2019041117530940400_B27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2265.1985.tb00160.x","article-title":"Congenital 11 beta-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families","volume":"22","author":"Shackleton","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019041117530940400_B28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng0895-394","article-title":"Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase","volume":"10","author":"Mune","year":"1995","journal-title":"Nat Genet"},{"issue":"3","key":"2019041117530940400_B29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and treatment of low-renin hypertension","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019041117530940400_B30","doi-asserted-by":"crossref","first-page":"E546","DOI":"10.3390\/ijms19020546","article-title":"The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor","volume":"19","author":"Baudrand","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2019041117530940400_B31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2019041117530940400_B32","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/jc.2016-3867","article-title":"Renin phenotypes characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity","volume":"102","author":"Hundemer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041117530940400_B33","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","article-title":"The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio","volume":"116","author":"Hood","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"2019041117530940400_B34","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.HYP.0000013784.18175.51","article-title":"Familial aggregation of low-renin hypertension","volume":"39","author":"Fisher","year":"2002","journal-title":"Hypertension"},{"issue":"9","key":"2019041117530940400_B35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/ajh\/hpt091","article-title":"Bimodal aldosterone distribution in low-renin hypertension","volume":"26","author":"Adlin","year":"2013","journal-title":"Am J Hypertens"},{"issue":"9","key":"2019041117530940400_B36","first-page":"1134","article-title":"Subclinical endothelial inflammation markers in a family with type I familial hyperaldosteronism caused by a de novo mutation [in Spanish]","volume":"136","author":"Stehr","year":"2008","journal-title":"Rev Med Chil"},{"issue":"9","key":"2019041117530940400_B37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF03346533","article-title":"Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha","volume":"32","author":"Carvajal","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"1-2","key":"2019041117530940400_B38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2014.08.003","article-title":"Aldosterone induces C-reactive protein expression via MR-ROS-MAPK-NF-\u03baB signal pathway in rat vascular smooth muscle cells","volume":"395","author":"Zhang","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2019041117530940400_B39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe\u2212\/\u2212 mice","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"2019041117530940400_B40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/HYPERTENSIONAHA.116.08966","article-title":"Renal dysfunction induced by kidney-specific gene deletion of hsd11b2 as a primary cause of salt-dependent hypertension","volume":"70","author":"Ueda","year":"2017","journal-title":"Hypertension"},{"issue":"9","key":"2019041117530940400_B41","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/ndt\/gfq197","article-title":"Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats","volume":"25","author":"Kawarazaki","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2019041117530940400_B42","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"2019041117530940400_B43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1152\/physiolgenomics.00053.2010","article-title":"In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence","volume":"42","author":"Manning","year":"2010","journal-title":"Physiol Genomics"},{"issue":"6","key":"2019041117530940400_B44","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.HYP.27.6.1193","article-title":"Apparent mineralocorticoid excess: genotype is correlated with biochemical phenotype","volume":"27","author":"Mune","year":"1996","journal-title":"Hypertension"},{"issue":"5","key":"2019041117530940400_B45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ajh.2011.263","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 2 polymorphisms and activity in a Chilean essential hypertensive and normotensive cohort","volume":"25","author":"Campino","year":"2012","journal-title":"Am J Hypertens"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/2\/595\/27437972\/jc.2018-01197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T02:18:37Z","timestamp":1555035517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/2\/595\/5096788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,9,14]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01197","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,9,14]]}}}